Dr. Shu Chien

 Shu Chien 300px

Dr. Shu Chien received his medical degree from National Taiwan University and Ph.D. in Physiology from Columbia University. He is a University Professor of Bioengineering and Medicine and Director of the Institute of Engineering in Medicine at University of California San Diego. His research focuses on molecular, cellular and integrative bioengineering. He has published over 500 original research papers and edited 14 books. As directors of NIH training grants at Columbia and UCSD since 1975, he has been responsible for the training of hundreds of predoctoral and postdoctoral trainees.

Dr. Chien has served in leadership positions in many professional organizations, including presidents of American Institute for Medical and Biological Engineering, American Physiological Society, Biomedical Engineering Society, Federation of American Societies of Experimental Biology, International Society of Biorheology, and Microcirculatory Society. He is a member of National Academy of Sciences, National Academy of Engineering, National Academy of Medicine, American Academy of Arts and Sciences, National Academy of Inventors, and Academia Sinica, as well as a foreign member of Chinese Academy of Sciences.

Dr. Chien has received many honors and awards, including Honorary Doctoral Degrees from six universities, Honorary Professorship from 16 universities, the Melville Medal (twice), Fahraeus Medal, Landis Award, ALZA Award, Zweifach Award, Poiseuille Medal, Galletti Award, Revelle Medal, Franklin Medal, Asian American Engineer of the Year, and the Founders Award of National Academy of Engineering. He is a recipient of the National Health Medal and Presidential Prize in Life Sciences in 2009 in Taiwan, ROC, and the National Medal of Science, the highest honor for scientists and engineers in USA, bestowed by President Obama in 2011.


Mr Robert Proulx

Robert proulx

Mr. Proulx is a veteran business executive with more than 25 years in leadership for both private and public companies in the life science and diagnostic device markets. Currently Mr. Proulx serves as President and CEO of Imagion Biosystems, a publicly traded company developing an early cancer detection technology.  Previously, he has served as Chief Commercial Officer and GM of U.S. Operations for Silicon Biosystems, and VP Sales & Marketing at both Nanogen and GeneLogic. He has also held board appointments at Semrock and PGXL Diagnostic Laboratories and has been a volunteer in the CONNECT Springboard Entrepreneurs in Residence program helping nurture start ups through early stage business planning.


Dr. Russell Doolittle


Russell Doolittle received his Ph.D. from Harvard University. He was named a Guggenheim Fellow and was elected to the National Academy of Sciences and the American Academy of Arts and Sciences. Professor Doolittle is a co-recipient of the Paul Ehrlich Prize.


Dr. Donald Helinski


 Don Helinski earned his Ph.D at Case Western University and held a postdoctoral fellowship at Stanford University. Before joining the faculty at UCSD, he was on the faculty at Princeton University. He is a member of the National Academy of Sciences and the American Academy of Arts and Sciences. He is also a Fellow of the American Association for the Advancement of Science and an elected member of the European Molecular Biology Organization and the American Academy of Microbiology.